280 related articles for article (PubMed ID: 31670864)
1. NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes.
Oksanen M; Hyötyläinen I; Trontti K; Rolova T; Wojciechowski S; Koskuvi M; Viitanen M; Levonen AL; Hovatta I; Roybon L; Lehtonen Š; Kanninen KM; Hämäläinen RH; Koistinaho J
Glia; 2020 Mar; 68(3):589-599. PubMed ID: 31670864
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress.
Ren P; Chen J; Li B; Zhang M; Yang B; Guo X; Chen Z; Cheng H; Wang P; Wang S; Wang N; Zhang G; Wu X; Ma D; Guan D; Zhao R
Oxid Med Cell Longev; 2020; 2020():3050971. PubMed ID: 32454936
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
4. Dual pathways mediate β-amyloid stimulated glutathione release from astrocytes.
Ye B; Shen H; Zhang J; Zhu YG; Ransom BR; Chen XC; Ye ZC
Glia; 2015 Dec; 63(12):2208-19. PubMed ID: 26200696
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease.
Prasad KN
Mech Ageing Dev; 2016 Jan; 153():41-7. PubMed ID: 26811881
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 Suppresses Oxidative Stress and Inflammation in
Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 Activates Nrf2 Pathway and Ameliorates Cell Damage in Cultured Cortical Astrocytes Exposed to Oxygen-Glucose Deprivation/Reperfusion Insults.
Wu L; Li HH; Wu Q; Miao S; Liu ZJ; Wu P; Ye DY
J Mol Neurosci; 2015 Aug; 56(4):848-857. PubMed ID: 25702137
[TBL] [Abstract][Full Text] [Related]
8. Brain Dicer1 Is Down-Regulated in a Mouse Model of Alzheimer's Disease Via Aβ42-Induced Repression of Nuclear Factor Erythroid 2-Related Factor 2.
Wang Y; Lian M; Zhou J; Wu S
Mol Neurobiol; 2020 Nov; 57(11):4417-4437. PubMed ID: 32737764
[TBL] [Abstract][Full Text] [Related]
9. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.
Yi C; Mei X; Ezan P; Mato S; Matias I; Giaume C; Koulakoff A
Cell Death Differ; 2016 Oct; 23(10):1691-701. PubMed ID: 27391799
[TBL] [Abstract][Full Text] [Related]
10. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
Prasad KN; Bondy SC
Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
[TBL] [Abstract][Full Text] [Related]
12. The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities.
De Plano LM; Calabrese G; Rizzo MG; Oddo S; Caccamo A
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979483
[TBL] [Abstract][Full Text] [Related]
13. FABP7 drives an inflammatory response in human astrocytes and is upregulated in Alzheimer's disease.
Hamilton HL; Kinscherf NA; Balmer G; Bresque M; Salamat SM; Vargas MR; Pehar M
Geroscience; 2024 Apr; 46(2):1607-1625. PubMed ID: 37688656
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons.
Eftekharzadeh B; Maghsoudi N; Khodagholi F
Biochimie; 2010 Mar; 92(3):245-53. PubMed ID: 20026169
[TBL] [Abstract][Full Text] [Related]
15. microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1/Nrf2/ARE signaling pathway.
Wu GD; Li ZH; Li X; Zheng T; Zhang DK
Exp Neurol; 2020 Feb; 324():113128. PubMed ID: 31759899
[TBL] [Abstract][Full Text] [Related]
16. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
17. Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?
Murphy KE; Park JJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561773
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes.
Liddell JR; Lehtonen S; Duncan C; Keksa-Goldsteine V; Levonen AL; Goldsteins G; Malm T; White AR; Koistinaho J; Kanninen KM
J Neuroinflammation; 2016 Feb; 13():49. PubMed ID: 26920699
[TBL] [Abstract][Full Text] [Related]
19. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.
Ruan L; Kang Z; Pei G; Le Y
Curr Alzheimer Res; 2009 Dec; 6(6):531-40. PubMed ID: 19747158
[TBL] [Abstract][Full Text] [Related]
20. Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action.
Sidiropoulou GA; Metaxas A; Kourti M
Front Endocrinol (Lausanne); 2023; 14():1217730. PubMed ID: 37465125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
